Abstract
P2X7 is an ATP-gated non-selective cation channel expressed primarily on cells of hematopoietic origin, such as macrophages and microglia. Since the initial cloning of this channel, enormous progress has been made in the understanding of the physiology, pharmacology and therapeutic utility of P2X7. This article attempts to review the biology of P2X7 with a focus on the complex pharmacology of this channel. Finally, the authors discuss the role of P2X7 as an analgesic drug target and raise some of the challenges and issues that face the P2X7 research community.
Keywords: P2X7, pain, IL-1β, inflammation, purinergic, ATP-gated non-selective cation channel, hematopoietic origin, macrophages, microglia, therapeutic utility of P2X7, Analgesic Drug Target, ATP gated ion channels, nonselective flux, currentvoltage relationship, P2X7 ACTIVATION AND MATURE IL-1 RELEASE
Current Pharmaceutical Biotechnology
Title: The Physiology, Pharmacology and Future of P2X7 as An Analgesic Drug Target: Hype or Promise?
Volume: 12 Issue: 10
Author(s): Anindya Bhattacharya, Robert A. Neff and Alan D. Wickenden
Affiliation:
Keywords: P2X7, pain, IL-1β, inflammation, purinergic, ATP-gated non-selective cation channel, hematopoietic origin, macrophages, microglia, therapeutic utility of P2X7, Analgesic Drug Target, ATP gated ion channels, nonselective flux, currentvoltage relationship, P2X7 ACTIVATION AND MATURE IL-1 RELEASE
Abstract: P2X7 is an ATP-gated non-selective cation channel expressed primarily on cells of hematopoietic origin, such as macrophages and microglia. Since the initial cloning of this channel, enormous progress has been made in the understanding of the physiology, pharmacology and therapeutic utility of P2X7. This article attempts to review the biology of P2X7 with a focus on the complex pharmacology of this channel. Finally, the authors discuss the role of P2X7 as an analgesic drug target and raise some of the challenges and issues that face the P2X7 research community.
Export Options
About this article
Cite this article as:
Bhattacharya Anindya, A. Neff Robert and D. Wickenden Alan, The Physiology, Pharmacology and Future of P2X7 as An Analgesic Drug Target: Hype or Promise?, Current Pharmaceutical Biotechnology 2011; 12 (10) . https://dx.doi.org/10.2174/138920111798357429
DOI https://dx.doi.org/10.2174/138920111798357429 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide
Current Medicinal Chemistry Recent Advances on the Antiatherogenic Effects of HDL-Derived Proteins and Mimetic Peptides
Current Pharmaceutical Design Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Current Drug Targets Demonstration of the Efficacy of Statins in Resolution of Plaque Inflammation by Serial FDG Imaging
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Natural Products as a Source of CNS-Active Agents
Mini-Reviews in Organic Chemistry Caveolae and Caveolin-1: Novel Potential Targets for the Treatment of Cardiovascular Disease
Current Pharmaceutical Design Multiplex Analysis of Cardiac Hypertrophic Signaling: Reduced in vivo Phosphorylation of Glycogen Synthase Kinase-3β and Proline-Rich Akt Substrate (PRAS40)
Current Signal Transduction Therapy Pyrazolo-Triazolo-Pyrimidine Derivatives as Adenosine Receptor Antagonists: A Possible Template for Adenosine Receptor Subtypes?
Current Pharmaceutical Design Bone Disruption and Environmental Pollutants
Endocrine, Metabolic & Immune Disorders - Drug Targets BHUx: A Patented Polyherbal Formulation to Prevent Hyperlipidemia and Atherosclerosis
Recent Patents on Inflammation & Allergy Drug Discovery Mechanisms for Progenitor Cell-Mediated Repair for Ischemic Heart Injury
Current Stem Cell Research & Therapy Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Contrast Media in Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Conference Proceedings: Second International Conference on Novel Psychoactive Substances (NPS) Swansea, UK; September 12-13th, 2013
Current Drug Abuse Reviews The Association of Connective Tissue Disorders with Cervical Artery Dissections
Current Molecular Medicine New Immunosuppressants: Immunosuppression and Immunomodulation
Medicinal Chemistry Reviews - Online (Discontinued) Periodontitis and Redox Status: A Review
Current Pharmaceutical Design Novel Pharmacologic Approaches to the Prevention and Treatment of Ulcerative Colitis
Current Pharmaceutical Design Matrix Metalloproteinases
Current Medicinal Chemistry Prostacyclin, Atherothrombosis, and Cardiovascular Disease
Current Medicinal Chemistry